The importance of the biological impact of exposure to the concept of the exposome

Environmental Health Perspectives

Volumn 124, Issue 10, 2016, Pages 1504-1510

  Dennis, Kristine K ^a   Auerbach, Scott S ^b   Balshaw, David M ^c   Cui, Yuxia ^c   Fallin, Margaret Daniele ^d   Smith, Martyn T ^e   Spira, Avrum ^f   Sumner, Susan ^g   Miller, Gary W ^a  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA SECRETASE 1; MICRORNA; MITOCHONDRIAL PROTEIN; SMALL INTERFERING RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALCOHOLISM; AUTISM; CANCER RISK; CATARACT; CHRONIC KIDNEY DISEASE; COLORECTAL CANCER; COPY NUMBER VARIATION; CYSTIC FIBROSIS; DNA DAMAGE; DOWN SYNDROME; ENVIRONMENTAL EXPOSURE; FRAGILE X SYNDROME; HEMOPHILIA; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN IMPACT (ENVIRONMENT); HUNTINGTON CHOREA; NEXT GENERATION SEQUENCING; NONALCOHOLIC FATTY LIVER; NOTE; PARKINSON DISEASE; PHENYLKETONURIA; PRIORITY JOURNAL; RNA INTERFERENCE; ANIMAL; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MONITORING; POLLUTANT; PRACTICE GUIDELINE; STATISTICS AND NUMERICAL DATA; TOXICITY;

ANIMALS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; GUIDELINES AS TOPIC; HUMANS;

EID: 84980385173     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/EHP140     Document Type: Note

References (42)

1. Athersuch T. 2016. Metabolome analyses in exposome studies: profiling methods for a vast chemical space. Arch Biochem Biophys 589:177–186, doi: 10.1016/j.abb.2015.10.007.
2. Balbo S, Turesky RJ, Villalta PW. 2014. DNA adductomics. Chem Res Toxicol 27(3):356–366, doi: 10.1021/tx4004352.
3. Brouwers MM, Besselink H, Bretveld RW, Anzion R, Scheepers PT, Brouwer A, et al. 2011. Estrogenic and androgenic activities in total plasma measured with reporter-gene bioassays: relevant exposure measures for endocrine disruptors in epidemiologic studies? Environ Int 37(3):557–564, doi: 10.1016/j.envint.2010.11.001.
4. Cui Y, Balshaw DM, Kwok RK, Thompson CL, Collman GW, Birnbaum LS. 2016. The exposome: Embracing the complexity for discovery in environmental health. Environ Health Perspect 124: A137–A140, doi:10.1289/EHP412.
5. Dennis KK, Marder ME, Balshaw DM, Cui Y, Lynes MA, Patti GJ, et al. 2016. Biomonitoring in the era of the exposome. Environ Health Perspect, doi:10.1289/ EHP474.
6. Doll R, Peto R. 1981. The causes of cancer: qualitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66(6):1191–1308.
7. Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, Luo M, et al. 2007. Activation of inflammation/NF-κB signaling in infants born to arsenic-exposed mothers. PLoS Genet 3(11):e207, doi: 10.1371/journal.pgen.0030207.
8. Ghantous A, Hernandez-Vargas H, Byrnes G, Dwyer T, Herceg Z. 2015. Characterising the epigenome as a key component of the fetal exposome in evaluating in utero exposures and childhood cancer risk. Mutagenesis 30(6):733–742, doi: 10.1093/ mutage/gev010.
9. Gibson G. 2008. The environmental contribution to gene expression profiles. Nat Rev Genet 9(8):575–581, doi: 10.1038/nrg2383.
10. Go YM, Walker DI, Liang Y, Uppal K, Soltow QA, Tran V, et al. 2015. Reference standardization for mass spectrometry and high-resolution metabolomics applications to exposome research. Toxicol Sci 148(2):531–543, doi: 10.1093/toxsci/kfv198.
11. He G, Tsutsumi T, Zhao B, Baston DS, Zhao J, Heath-Pagliuso S, Denison MS. 2011. Third-generation Ah receptor-responsive luciferase reporter plasmids: amplification of dioxin-responsive elements dramatically increases CALUX bioassay sensitivity and responsiveness. Toxicol Sci 123(2):511–522, doi: 10.1093/toxsci/kfr189.
12. Heijmans BT, Tobi WE, Stein AD, Putter H, Blauw GJ, Susser ES, et al. 2008. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 105(44):17046–17049, doi: 10.1073/pnas.0806560105.
13. Ho SM, Johnson A, Tarapore P, Janakiram V, Zhang X, Leung YK. 2012. Environmental epigenetics and its implication on disease risk and health outcomes. ILAR J 53(3–4):289–305, doi: 10.1093/ilar.53.3-4.289.
14. Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(suppl):245–254.
15. Kanehisa M, Goto S. 2000. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 28:27–30.
16. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. 2000. Environmental and heritable factors in the causation of cancer— analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85.
17. Lumey LH, Stein AD, Kahn HS, van der Pal-de Bruin KM, Blauw GJ, Zybert PA, et al. 2007. Cohort profile: the Dutch Hunger Winter Families study. Int J Epidemiol 36(6):1196–1204.
18. McEwen BS. 1998. Stress, adaptation, and disease. Allostasis and allostatic load. Ann NY Acad Sci 840:33–44.
19. McEwen BS, Wingfield JC. 2003. The concept of allostasis in biology and biomedicine. Horm Behav 43(1):2–15.
20. Miller GW, Jones DP. 2014. The nature of nurture: refining the definition of the exposome. Toxicol Sci 137(1):1–2, doi: 10.1093/toxsci/kft251.
21. Mitchell C, Hobcraft J, McLanahan SS, Siegel SR, Berg A, Brooks-Gunn J, et al. 2014. Social disadvantage, genetic sensitivity, and children’s telomere length. Proc Natl Acad Sci USA 111(16):5944–5949, doi: 10.1073/pnas.140429311.
22. Needham BL, Adler N, Gregorich S, Rehkopf D, Lin J, Blackburn EH, et al. 2013. Socioeconomic status, health behavior, and leukocyte telomere length in the National Health and Nutrition Examination Survey, 1999–2002. Soc Sci Med 85:1–8, doi: 10.1016/j.socscimed.2013.02.023.
23. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. 2008. J Clin Endocrinol Metab 93(5):1526–1540, doi: 10.1210/ jc.2008-0125.
24. NIEHS (National Institute of Environmental Health Sciences). 2015. Children’s Health Exposure Analysis Resource (CHEAR). https://www.niehs.nih.gov/research/supported/dert/programs/chear/index.cfm [accessed 1 September 2015].
25. NRC (National Research Council). 1987. Biological markers in environmental health research. Committee on Biological Markers of the National Research Council. Environ Health Perspect 74:3–9.
26. Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, et al. 2013. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 14(11):1112–1120, doi: 10.1016/ S1470-2045(13)70366-8.
27. Patel CJ, Chen R, Kodama K, Ioannidis JPA, Butte AJ. 2013. Systematic identification of interaction effects between genome- and environment-wide associations in type 2 diabetes mellitus. Hum Genet 13(5):495–508, doi: 10.1007/s00439-012-1258-z.
28. Poirier MC, Santella RM, Weston A. 2000. Carcinogen macromolecular adducts and their measurement. Carcinogenesis 21(3):353–359.
29. Polderman TJ, Benyamin B, de Leeuw CA, Sullivan PF, van Bochoven A, Visscher PM, et al. 2015. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet 47(7):702–709, doi: 10.1038/ng.3285.
30. Rappaport SM, Li H, Grigoryan H, Funk WE, Williams ER. 2012. Adductomics: Characterizing exposures to reactive electrophiles. Toxicol Lett 213(1):83–90, doi: 10.1016/j.toxlet.2011.04.002.
31. Rappaport SM, Smith MT. 2010. Epidemiology. Environment and disease risks. Science 330(6003):460–461, doi: 10.1126/science.1192603.
32. Remington PL, Brownson RC. 2011. Fifty years of progress in chronic disease epidemiology and control. MMWR Suppl 60(4):70–77.
33. Smith MT, de la Rosa R, Daniels SI. 2015. Using exposomics to assess cumulative risks and promote health. Environ Mol Mutagen 56(9):715–723, doi: 10.1002/em.21985.
34. Su LJ, Fiehn O, Maruvada P, Moore SC, O’Keefe SJ, Wishart DS, et al. 2014. The use of metabolomics in population-based research. Adv Nutr 5(6):785–788, doi: 10.3945/an.114.006494.
35. Sumner SCJ, Fennell TR. 2007. Biomarkers, omics, and species comparisons. Human Ecol Risk Assess 13(1):111–119, doi: 10.1080/10807030601107510.
36. Tice RR, Austin CP, Kavlock RJ, Bucher JR. 2013. Improving the human hazard characterization of chemicals: a Tox21 update. Environ Health Perspect 121:756–765, doi: 10.1289/ehp.1205784.
37. Vineis P, Khan AE, Vlaanderen J, Vermeulen R. 2009. The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability. Environ Health 8:54, doi: 10.1186/1476-069X-8-54.
38. Vlaanderen J, Moore LE, Smith MT, Lan Q, Zhang L, Skibola CF, et al. 2010. Application of OMICS technologies in occupational and environmental health research; current status and projections. Occup Environ Med 67(2):136–143, doi: 10.1136/ oem.2008.042788.
39. Wild CP. 2005. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 14(8):1847–1850.
40. Willett WC. 2002. Balancing life-style and genomics research for disease prevention. Science 296(5568):695–698.
41. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, et al. 2013. HMDB 3.0—the Human Metabolome Database in 2013. Nucleic Acids Res 41(database issue):D801–D807, doi: 10.1093/nar/gks1065.
42. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. 2007. HMDB: the Human Metabolome Database. Nucleic Acids Res 35(database issue):D521–D526.